Gammagard®

GAMMAGARD LIQUID is indicated as replacement therapy for primary humoral immunodeficiency (PI) in adult and pediatric patients two years of age or older. This includes, but is not limited to, common variable immunodeficiency (CVID), X-linked agammaglobulinemia, congenital agammaglobulinemia, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies.

GAMMAGARD LIQUID is indicated as a maintenance therapy to improve muscle strength and disability in adult patients with Multifocal Motor Neuropathy (MMN).

For indications, dosing and other information, please refer to the prescribing information.

GAMMAGARD LIQUID ‐ Baxalta

Size:
1 gram vial
NDC #:
00944-2700-02
Download:
PI
Size:
2.5 gram vial
NDC #:
00944-2700-03
Download:
PI
Size:
5 gram vial
NDC #:
00944-2700-04
Download:
PI
Size:
10 gram vial
NDC #:
00944-2700-05
Download:
PI
Size:
20 gram vial
NDC #:
00944-2700-06
Download:
PI
Size:
30 gram vial
NDC #:
00944-2700-07
Download:
PI